Use of Clinical Risk Score in an Elderly Population: Need for Ad Hoc Validation and Calibration

In a recent issue of the Journal, Costa et al. [(1)][1] suggested that bleeding risk should drive long-term dual antiplatelet therapy (DAPT) after complex percutaneous coronary intervention (PCI), a marker of increased ischemic risk. However, there are concerns when generalizing results in an